Adenylate Kinase 2 (AK2) (Middle Region) Peptide
AK2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN973045
Aperçu rapide pour Adenylate Kinase 2 (AK2) (Middle Region) Peptide (ABIN973045)
Antigène
Adenylate Kinase 2 (AK2)
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- LIHPKSGRSY HEEFNPPKEP MKDDITGEPL IRRSDDNEKA LKIRLQAYHT
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-AK2 Antibody(ARP46058_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Adenylate Kinase 2 (AK2)
-
Sujet
-
Adenylate kinases are involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate groups among adenine nucleotides. Three isozymes of adenylate kinase, namely 1, 2, and 3, have been identified in vertebrates. Expression of these isozymes is tissue-specific and developmentally regulated. Isozyme 2 is localized in the mitochondrial intermembrane space and may play a role in apoptosis.
Alias Symbols: ADK2, AK 2
Protein Interaction Partner: SHBG,MEPCE
Protein Size: 239 -
Poids moléculaire
- 26 kDa
-
ID gène
- 204
-
NCBI Accession
- NM_001625, NP_001616
-
UniProt
- P54819
Antigène
-
Vous êtes ici:
